Stocks and Investing
Stocks and Investing
Wed, June 28, 2023
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
[ Wed, Jun 28th 2023
] - WOPRAI
Tue, June 27, 2023
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
Bill Sutherland Downgraded (AMED) to Hold on, Jun 27th, 2023
Bill Sutherland of Benchmark, Downgraded "Amedisys, Inc." (AMED) to Hold on, Jun 27th, 2023.
Bill has made no other calls on AMED in the last 4 months.
There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, all agree with Bill's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jonathan Yong of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $100 on, Tuesday, June 6th, 2023
- Sarah James of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $100 on, Tuesday, June 6th, 2023
- Gary Taylor of "TD Cowen" Maintained at Hold with Decreased Target to $84 on, Monday, May 8th, 2023
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $88 on, Friday, May 5th, 2023
- Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $103 on, Thursday, May 4th, 2023
Contributing Sources